← Open Payments lookup

ASA MAIR: Open Payments

NPI 1306458062 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,369 in 156 payments from 18 companies in 2025. Trend: 2023 $550 · 2024 $2,077 · 2025 $2,369

Food & beverage: $2,259Education: $109
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.21$273
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$272
Alkermes, Inc.19$258
ABBVIE INC.19$246
Teva Pharmaceuticals USA, Inc.9$240
Otsuka America Pharmaceutical, Inc.16$192
Vanda Pharmaceuticals Inc.13$166
E.R. Squibb & Sons, L.L.C.14$162
Axsome Therapeutics, Inc.9$150
Neurocrine BioSciences, Inc.3$96

Products named: Qelbree, CAPLYTA, ARISTADA, REXULTI, VRAYLAR, FANAPT, COBENFY, Auvelity.

Industry payments across CA — which companies pay providers there.